First Trust NYSE Arca Biotechnology Index Fund logo

First Trust NYSE Arca Biotechnology Index Fund (BFBI39)

Market Closed
13 Jul, 19:55
B3 B3
R$
58. 24
-3.06
-4.9918%
R$
- Market Cap
- Div Yield
1 Volume
R$ 61.3
Previous Close
Add Transaction
Day Range
58.24 58.24
Year Range
45 61.3
Want to track BFBI39 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BFBI39 closed Monday lower at R$58.24, a decrease of -4.9918% from Friday's close, completing a monthly increase of 0% or R$0. Over the past 12 months, BFBI39 stock gained 2.4991%.
BFBI39 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

BFBI39 Chart

First Trust NYSE Arca Biotechnology Index Fund (BFBI39) FAQ

What is the stock price today?

The current price is R$58.24.

On which exchange is it traded?

First Trust NYSE Arca Biotechnology Index Fund is listed on B3.

What is its stock symbol?

The ticker symbol is BFBI39.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has First Trust NYSE Arca Biotechnology Index Fund ever had a stock split?

No, there has never been a stock split.

First Trust NYSE Arca Biotechnology Index Fund Profile

B3 Exchange
Brazil Country

Overview

This financial entity operates as an investment fund focusing predominantly on the biotechnology sector. It is structured to track the performance of 30 leading biotechnology companies, employing a strategic approach by allocating at least 90% of its net assets (this includes any borrowed investments) directly into the securities that form the basis of its targeted index. The index itself is constructed on an equal-dollar weighted basis, ensuring that each company within the index has an equal influence on the fund's overall performance. This method is designed to provide investors with a diversified exposure to the biotechnology industry, capturing the growth and innovation within this sector.

Products and Services

  • Biotechnology Equity Investments

    The primary offering of this fund revolves around equity investments in biotechnology companies. By focusing on 30 leading firms within the sector, the fund aims to tap into the growth potential of biotechnological advancements and innovations. This approach allows investors to gain exposure to a wide array of companies developing novel therapies, medical devices, and diagnostic tools, among other contributions to the healthcare sector.

Contact Information

Address: -
Phone: -